Propionibacterium freudenreichii, identified in a gut microbiome test, is a significant bacterium that offers intriguing insights into the health and balance of the gut ecosystem. This species is part of the Propionibacterium genus, known for its unique metabolic properties, particularly in the production of propionic acid – a beneficial short-chain fatty acid (SCFA) with several important roles in gut health. SCFAs, like propionic acid, are crucial for maintaining the health of the colon, regulating the immune system, and ensuring the integrity of the gut barrier.

Propionylglycine is a N-acylglycine obtained by formal condensation of the carboxy group of propionic acid with the amino group of glycine. It has a role as a human urinary metabolite. It is functionally related to a propionic acid. It is a conjugate acid of a propionylglycinate. 

Prostaglandin D2 (PGD2) is a bioactive lipid compound that plays a significant role in various physiological and pathological processes within the human body. It belongs to the family of prostaglandins, which are a group of physiologically active lipid compounds having diverse hormone-like effects in animals. PGD2 itself is produced primarily by mast cells, which are cells involved in the immune response, and it is derived from arachidonic acid through the action of the enzyme prostaglandin D synthase. This compound has several important roles, including the mediation of allergic responses and inflammation. In the context of allergies, PGD2 can cause symptoms such as bronchoconstriction and vasodilation. It's also involved in the regulation of sleep-wake cycles and acts as a neuromodulator in the brain.

Prostaglandins are lipid autacoids derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. 

Total Prostate Specific Antigen (TPSA) is a serine protease produced by prostate cells, primarily used as a biomarker for the screening and monitoring of prostate cancer. While elevated TPSA levels can indicate the presence of prostate cancer, they can also arise from benign conditions such as benign prostatic hyperplasia (BPH) and prostatitis. The TPSA test measures the total amount of PSA in the blood, which includes both free and protein-bound forms. Although TPSA is a valuable tool in early detection and management of prostate cancer, its specificity is limited, as elevated levels can occur in non-cancerous conditions. Therefore, healthcare providers often use additional tests, such as the free-to-total PSA ratio, to improve diagnostic accuracy and differentiate between benign and malignant prostate conditions.

The prostate-specific antigen (PSA) test measures the amount of PSA protein in your blood, which is produced by both normal and abnormal cells in the prostate gland. While higher PSA levels can be linked to prostate cancer, they can also result from non-cancerous conditions such as prostatitis, urinary tract infections, or benign prostate enlargement (BPH). Certain medications and recent activities like ejaculation or vigorous exercise can also influence results. There is no single “normal” PSA level—values often vary by age, race, and individual health factors. Instead, doctors look at trends over time, known as PSA velocity, to help determine whether further evaluation, such as imaging or biopsy, is needed.

Prostatic Acid Phosphatase (PAP) is an enzyme produced by prostate cells and historically used as a tumor marker for prostate cancer, particularly advanced or metastatic disease. While largely replaced by Prostate-Specific Antigen testing for screening, PAP remains clinically relevant in specific cases. It is often used alongside PSA to provide additional insight into disease progression, prognosis, and response to therapy, especially when PSA results are inconclusive.

Urine protein tests detect and/or measure protein being released into the urine. If the kidneys are damaged or compromised due to other conditions, they become less effective at filtering, causing detectable amounts of protein to spill over into the urine.

Protein C is a vitamin K-dependent plasma protein. 

Protein C helps control blood clotting. A lack of this protein or a problem with the function of this protein may cause blood clots to form in veins. The test is also used to screen relatives of people who are known to have protein C deficiency. It may also be done to find the reason for repeated miscarriages.

Protein S is a critical component of the body's anticoagulation system, playing a pivotal role in regulating blood clot formation. It is a glycoprotein that circulates in the bloodstream and acts as a cofactor for protein C, another important anticoagulant protein. The primary function of protein S is to enhance the activity of activated protein C (APC) in breaking down coagulation factors Va and VIIIa, thus inhibiting the formation of excessive blood clots.

The 24-hour urine protein test measures the amount of protein excreted in urine over a 24-hour period. This can help detect kidney disease or other conditions that affect kidney function. The normal range for this test is less than 150 milligrams per day. Factors that can affect the results include dehydration, recent contrast material for an x-ray, vaginal fluids in urine, severe stress, strenuous exercise, and urinary tract infections

The "Protein, Total, 24 HR Urine" marker in this panel is a critical measure for evaluating kidney function and detecting kidney disorders. It quantifies the total amount of protein excreted in urine over a 24-hour period. Normally, healthy kidneys filter blood and retain most proteins, preventing significant protein loss in urine. Therefore, an elevated total protein level in a 24-hour urine collection can be a sign of proteinuria, indicating kidney damage or disease. Conditions such as glomerulonephritis, diabetic nephropathy, or hypertension-related kidney damage can lead to increased urinary protein excretion. This marker is essential for diagnosing and monitoring these conditions, providing insights into the severity of kidney impairment and the effectiveness of treatment strategies. Accurate 24-hour urine collection is crucial for this measurement, as it reflects the total protein excretion more reliably than a single or random urine sample.

Protein, Total, Random Ur (sometimes labelled "protein total random urine," "urine protein random," or "URN total protein") measures how much protein is present in a randomly collected urine sample. The reference range is 5–24 mg/dL. A result of "<4 mg/dL" — the most common result on this test — means protein was below the detection threshold, which is a reassuring finding indicating the kidneys are retaining protein appropriately. Elevated protein (above 24 mg/dL on a random sample) may reflect kidney dysfunction, but a single elevated result is common from exercise, illness, or dehydration and requires repeat testing before clinical conclusions are drawn.

A urine protein dipstick test checks if protein is leaking into the urine, which can be an early sign of kidney disease, especially in people with high blood pressure, diabetes, or abnormal kidney blood tests (creatinine, eGFR). Results are reported as Negative (normal), Trace (very small amount, often temporary), or graded 1+ to 4+ (increasing protein, more concerning). Temporary positives may occur with strenuous exercise, fever, dehydration, UTIs, or during pregnancy. If protein is found, your healthcare provider may repeat the test with a first-morning sample and order more precise measurements (uACR or UPCR), along with related kidney and blood pressure evaluations. Staying hydrated, controlling blood pressure and blood sugar, and avoiding heavy workouts before testing can improve accuracy and kidney health.